Source: @norml
Posted By: norml@weedconnection.com
media :: news - Sat, 26 Oct 2013 04:20:21 PST
Gallup: Nationwide Support For Legalizing Marijuana At Record Levels
Princeton, NJ: A record 58 percent of Americans nationwide now believe that marijuana ought to be "made legal" for adult consumption, according to survey data released this week by Gallup.
Americans' support for legalizing marijuana rose ten percent since Gallup previously posed the question last year. Only 39 percent of Americans now say that they oppose legalizing pot.
Pollsters attributed the rapid rise in support for legalization to changing attitudes among self-identified Independent voters. In 2012, 50 percent of Independents endorsed legalization, compared to 62 percent in 2013. Support among Democratic (65 percent) and Republican (35 percent) voters was little changed from 2012 to 2013.
Respondents in every age category except for those age 65 and over expressed majority support for legalization.
"Americans' support for legalization accelerated as the new millennium began," Gallup reported. "[I]t is likely that this momentum will spur further legalization efforts across the United States."
The Gallup poll randomly sampled 1,028 adults age 18 and older and possesses a margin of error of +/- 4 percent.
In recent months, polls in numerous states, including Louisiana, Maryland, and Texas, have shown majority support for regulating cannabis for adult consumers.
California: 65 Percent Of Likely Voters Would Back Statewide Measure To Regulate And Tax Retail Marijuana Sales
San Francisco, CA: Nearly two-thirds of likely California voters would support a statewide ballot measure to legalize and regulate marijuana production and retail sales, according to survey data conducted by Tulchin Research and commissioned by the state affiliate of the American Civil Liberties Union.
Sixty-five percent of respondents said that they would support a ballot proposal "to legalize, regulate, and tax marijuana in California for adults." Only 32 percent of those surveyed said that they would oppose such a measure.
A strong majority of self-identified Democratic (74 percent) and Independent/non-affiliated (72 percent) voters, but not Republican (47 percent) voters backed the proposal. African-Americans (74 percent), Caucasians (69 percent), and Asians (68 percent) also expressed strong support legalizing cannabis. Men and women were virtually equal in their support. Respondents in every age category, including those age 65 and older, expressed majority support for legalization.
The results of a separate Public Policy Institute of California poll released earlier this month reported that 60 percent of likely California voters support legalizing the plant's possession and sale for adults.
The ACLU poll surveyed 1,200 likely California voters and possesses a margin of error of +/- 3.1 percent.
The ACLU also announced the formation of the blue-ribbon panel to study ways to regulate cannabis in California. The panel will be headed by state Lt. Gov. Gavin Newsom. It is expected to convene for the next 18 to 24 months before making its recommendations.
More information @ https://www.aclunc.org
FDA Approves Investigational Trials Assessing Cannabidiol For Pediatric Epilepsy
Washington, DC: The US Food and Drug Administration has approved two clinical trials to assess the efficacy of cannabidiol (CBD), a nonpsychoactive plant cannabinoid, in the treatment of intractable pediatric epilepsy. The two approved trials will take place at New York Medical School and at the University of California at San Francisco, according to an online report in the journal O'Shaughnessy's. The cannabidiol formulations in the trials will be provided by British biotechnology firm GW Pharmaceuticals, which produces organic cannabinoid extract medicines, including Sativex.
Cannabidiol has been documented to possess a variety of therapeutic properties in preclinical models, including anti-epileptic activity. Clinical trials have shown the oral administration of CBD to be "safe and well tolerated" in healthy subjects.
In recent months, several national broadcasts have highlighted the use of CBD-rich oils to treat seizures associated with a pediatric form of intractable epilepsy known as Dravet Syndrome.
More information @ https://www.beyondthc.com/comes-now-epidiolex-fda-approves-ind-studies-of-cbd
Pharmacy Group Announces Formation Of Medical Marijuana Task Force
Alexandria, VA: The National Association of Specialty Pharmacy (NASP) has announced its intent to establish a task force to better educate pharmacists to the management of cannabis therapy.
"Medical marijuana has come to the forefront of patient care in many of the diseases that Specialty Pharmacists treat including Multiple Sclerosis, Cancer, HIV and others," the association stated in a press release. "More education for physicians, pharmacists and patients is needed to ensure individuals receive the correct product with the correct efficacy and drug delivery system to fit their disease. As an organization, NASP believes that it has the responsibility, intellectual advisors and obligation to take the lead on this emerging area of medical care."
According to the NASP website, the association - founded in 2012 - "represents specialty pharmacy professionals in all practice settings and highlights the unique value its members bring to patients and the healthcare system by focusing on building collaboration among all industry associations to improve patient outcomes."
More information @ https://www.nasprx.org
(c) Copyright 2006-2420 - WeedConnection LLC - ALL RIGHTS RESERVED
#Support Your #OG @WeedConnection! (Click Here)
